Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07827521) titled 'Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: First Affiliated Hospital of Wenzhou Medical University
Condition:
Chronic Limb-Threatening Ischemia
Diabetic Foot Ulcer
Infrapopliteal Arterial Occlusive Disease
Intervention:
Procedure: Lower-Extremity Revascularization
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 20, 20...